Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei
Introduction: Pseudomyxoma Peritonei (PMP) is an extremely rare disease characterized by progressive accumulation of mucinous ascites and implants in the peritoneum. We investigated the prognostic value for response to cytoreductive surgery (CRS) or hyperthermic intraperitoneal chemotherapy (HIPEC)...
Saved in:
Main Authors: | Ruiqing Ma, Guojun Li, Yingjiang Ye, Lei Liang, Chong Wang, Haipeng Zhou, Pu Zhang, Lubiao An, Guanjun Shi, Qian Chen, Hongbin Xu, Zhidong Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325000105 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent Incisional Hernia due to Pseudomyxoma Peritonei
by: Zafer Ergul, et al.
Published: (2011-01-01) -
Molecular characterization of Pseudomyxoma peritonei with single-cell and bulk RNA sequencing
by: Ye Jin Ha, et al.
Published: (2025-02-01) -
Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature
by: Ting Yan, et al.
Published: (2025-01-01) -
A case of giant low grade appendiceal mucinous neoplasm with pseudomyxoma peritonei
by: Yonghui Hou, et al.
Published: (2025-02-01) -
Decoding mutational signatures in breast cancer: Insights from a multi-cohort study
by: Margaux Betz, et al.
Published: (2025-03-01)